Glass House Brands Board of Directors Establishes Product Expansion Committee to Support New Product and Business Development
MWN-AI** Summary
Glass House Brands Inc., a prominent vertically-integrated cannabis company based in the U.S., has announced the formation of a Special Committee within its Board of Directors aimed at guiding product and business expansion beyond its established California operations. The committee, which will evaluate potential partnerships in the cannabis industry, includes key figures such as Kyle Kazan, the Company's Co-Founder and CEO, and experienced independent directors like Jay Nichols and Alison Payne, with Nichols taking on the role of Chairman.
The creation of this committee comes as the Company anticipates new opportunities coinciding with potential cannabis rescheduling by the Attorney General, which could open avenues in both domestic and international markets, particularly in medical cannabis and CBD sectors. The CBD market alone is projected to reach a staggering $30 billion, influenced by forthcoming developments in cannabis policy and consumer demand.
Kazan expressed confidence that Glass House is poised to leverage its extensive cultivation capabilities—built over a decade—to meet rising market demands and to engage with traditional industry players for collaborative opportunities. The establishment of this committee is seen as crucial in identifying and acting upon new prospects, including partnerships with leading product developers.
The Company is actively expanding its operations, evidenced by the construction of new greenhouses that will enhance its cultivation capacity and facilitate planned distributions to European medical markets. Nichols emphasized the importance of Halglass House’s low-cost, high-quality cannabinoid production in navigating this evolving landscape and building partnerships that harness established industry strengths in production and brand development.
With its comprehensive portfolio of cannabis brands and retail presence in California, Glass House Brands aims to position itself as a leader in the burgeoning cannabis marketplace.
MWN-AI** Analysis
Glass House Brands Inc. (CBOE CA: GLAS.A.U) has made a strategic move by forming a Special Committee within its Board of Directors to spearhead product expansion and business development. This committee's formation is timely as the company prepares for potential market shifts, primarily driven by anticipated reforms in cannabis legislation, including rescheduling to Schedule III. This change is projected to open avenues for international markets and significantly boost the financial outlook for companies engaged in cannabis production, particularly the Medicare-reimbursable CBD market, which could be valued at around $30 billion.
As Glass House ramps up its cultivation capacity with the ongoing construction of Greenhouses 2 and 4, investors should assess the company’s operational scalability. The company’s ability to produce high-quality cannabis at a competitive cost positions it favorably in a rapidly evolving market landscape. The unique expertise on the newly formed committee, especially with members like Jay Nichols, who brings extensive corporate strategic experience, and Alison Payne, an expert in branding, suggests Glass House is committed to leveraging expertise across various sectors to enhance its market presence.
Investors should view this initiative as a potential catalyst for future growth. By actively engaging with traditional industry participants and expanding into ancillary markets, Glass House is poised to capitalize on the growing acceptance of cannabinoid-based products. However, investors must also remain cautious of the inherent volatility in the cannabis sector and the ongoing regulatory uncertainties.
In conclusion, while the establishment of the Special Committee indicates a proactive approach to growth, potential investors should conduct thorough due diligence, considering both the opportunities and risks associated with this emerging market. Monitoring regulatory developments and Glass House's execution of its strategic plans will be crucial for assessing future performance.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
LONG BEACH, Calif. and TORONTO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF), one of the fastest-growing, vertically-integrated cannabis companies in the U.S., today announced the establishment of a Special Committee of its Board of Directors (“the Board”) to oversee new products and business expansion beyond the Company’s legacy California cannabis business and to evaluate ongoing and future partnership opportunities with traditional industry participants.
The Special Committee consists of Board members Kyle Kazan, Co-Founder, Chairman and CEO of Glass House, Graham Farrar, Co-Founder and President, Co-Founder Joceyln Rosenwald; and Independent Directors Jay Nichols and Alison Payne.
Mr. Nichols has been appointed Chairman of the Special Committee. He has over four decades of experience in corporate strategy and operations, having most recently served as Chairman of the Board and Interim CEO of Protective Insurance Company, and prior to that as CEO of Axis Reinsurance Ltd.
Ms. Payne is an expert in branding and marketing, with extensive experience in driving brand growth across multiple categories including beer, spirits, snacks and breakfast foods in the US and Europe. She also currently serves as the Chief Marketing Officer of Heineken, USA.
“As we await the final rescheduling order from Attorney General Pam Bondi, we are actively preparing for the related new business opportunities we are confident will be forthcoming,” said Kyle Kazan, Co-Founder, Chairman, and CEO of Glass House. “This committee’s mandate is to evaluate prospects and ensure our organization is fully prepared to capitalize on these opportunities as they arise, driven by building momentum in cannabis reform.”
“We remain confident that rescheduling cannabis to Schedule III can provide cannabis export opportunities to international medical markets in the near term and believe that Glass House is uniquely qualified to supply the Medicare reimbursable CBD market. Related to this, we are also excited by the President’s announced creation of a reimbursable CBD program, potentially with an annual market size of $30 Billion, which, combined with rescheduling would drive greater investment into the development of cannabis and hemp-based products across an array of traditional industry consumer product categories to support rising demand. Given that we’ve been growing cannabis for over 10 years, we have developed products and can cultivate input materials at a scale and price that is unmatched in the industry, which should dovetail into these new opportunities.”
“To meet this demand, we have already accelerated cultivation and production expansion with the announced buildouts of Greenhouses 2 and 4, which greatly increase our cultivation capacity. We are also actively engaged with future distribution partners to supply medical cannabis markets in Europe upon rescheduling as well as international CBD and hemp markets later this year. Forming this Special Product Expansion Committee is a key part of our strategy, improving how we find and act on new opportunities—such as partnerships with top product and brand developers—that go beyond what we are currently doing. As traditional industry companies develop cannabinoid-based products and brands, we want branded Glass House California cannabis inside.”
Mr. Nichols, Chairman of the Special Committee, added, “We are at a crossroads of mainstream adoption for cannabinoid products, and Glass House is well-positioned for success in the evolving landscape. I am excited to collaborate with the other members of this committee as well as members of the Company’s senior management team to explore ways in which Glass House can best utilize its core competency of low cost, high quality cannabinoid production to thrive within this changing world while partnering with legacy industry companies to leverage their leading capabilities on production, distribution and brand development.”
About Glass House Brands
Glass House is one of the fastest-growing, vertically integrated cannabis companies in the U.S., with a dedicated focus on the California market and building leading, lasting brands to serve consumers across all segments. Whether it be through its portfolio of brands, which includes Glass House Farms, PLUS Products, Allswell and Mama Sue Wellness or its network of retail dispensaries throughout the state of California, which includes The Farmacy, Natural Healing Center and The Pottery, Glass House is committed to realizing its vision of excellence: outstanding cannabis products, produced sustainably, for the benefit of all. For more information and company updates, visit www.glasshousebrands.com/ and https://ir.glasshousebrands.com/contact/email-alerts/.
Forward Looking Statements
This news release contains certain forward-looking information and forward-looking statements, as defined in applicable securities laws (collectively referred to herein as “forward-looking statements”). Forward-looking statements reflect current expectations or beliefs regarding future events or the Company’s future performance or financial results. All statements other than statements of historical fact are forward-looking statements. Often, but not always, forward- looking statements can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “continues”, “forecasts”, “projects”, “predicts”, “intends”, “anticipates”, “targets” or “believes”, or variations of, or the negatives of, such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “should”, “might” or “will” be taken, occur or be achieved. Forward-looking statements in this news release include, without limitation, statements regarding the Company’s financial outlook or operational plans and statements related to future market conditions. All forward-looking statements, including those herein, are qualified by this cautionary statement. Although the Company believes that the expectations expressed in such statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the statements. Accordingly, readers should not place undue reliance on forward-looking statements. There are certain factors that could cause actual results to differ materially from those in the forward-looking information, including those risks disclosed in the Company’s Annual Information Form available on SEDAR+ at www.sedarplus.ca and in the Company’s Form 40-F available on EDGAR at www.sec.gov. For more information on the Company, investors are encouraged to review the Company's public filings on SEDAR+ at www.sedarplus.ca. The forward-looking statements and financial outlooks contained in this news release speak only as of the date of this news release or as of the date or dates specified in such statements. The Company disclaims any intention or obligation to update or revise any forward- looking information, whether as a result of new information, future events or otherwise, other than as required by law.
For further information, please contact:
Glass House Brands Inc.
Jon DeCourcey, Vice President of Investor Relations
T: (781) 724 6869
E: ir@glasshousebrands.com
Investor Relations Contact:
KCSA Strategic Communications
Phil Carlson
T: 212-896-1233
E: GlassHouseIR@kcsa.com
FAQ**
How is Glass House Brands Inc - Class A GLASF positioning itself to navigate the evolving cannabis regulatory landscape in Long Beach, California, amidst potential opportunities arising from federal rescheduling?
What strategies is Glass House Brands Inc - Class A GLASF implementing to expand its product offerings and reach new consumer markets in Toronto, considering the anticipated change in the cannabis regulatory environment?
In light of Glass House Brands Inc - Class A GLASF's commitment to quality and sustainability, how does the company plan to enhance its production capabilities while exploring international partnerships, particularly in medical cannabis markets?
With an eye toward the potential $30 billion CBD market, how does Glass House Brands Inc - Class A GLASF intend to leverage its existing infrastructure in Long Beach to capitalize on new business opportunities and partnerships?
**MWN-AI FAQ is based on asking OpenAI questions about Glass House Brands Inc - Class A (OTC: GLASF).
NASDAQ: GLASF
GLASF Trading
0.12% G/L:
$8.21 Last:
6,153 Volume:
$8.02 Open:
